Third Harmonic Bio ( NASDAQ: THRD) will be liquidating the company and selling its remaining assets, the company said on ...

Urticaria or hives is a skin condition causing itchy red welts from various triggers Read ahead know its symptoms and why it ...

There have been new developments in treatments for chronic spontaneous urticaria, with dupilumab, remibrutinib, and barzolvolimab showing complete response in patients, particularly among those who ...

This article looks at contact urticaria in more detail, including its causes, risk factors, symptoms, and treatment. Contact urticaria is an immediate and short lived reaction to a certain ...

Patients with chronic spontaneous urticaria experienced a long delay in diagnosis, a substantial impact on their quality of life, and often received inadequate treatment, highlighting the need for ...

The following is a summary of “Dupilumab Improves Urticaria-Specific Quality of Life in Patients with Chronic Spontaneous ...

Varroa mites and small hive beetles are threatening Australian honey producers. Here’s how backyard beekeepers, and everyday ...

Evommune, Inc., a clinical stage biotechnology company discovering and developing new ways to treat immune-mediated inflammatory diseases, today announced the enrollment of the first patient in a ...

Urticaria highlights from AAD 2025 include late-breaking results from a phase 1b/2a study of the anti-c-Kit antibody placulumab, and positive results from the phase 3 studies of remibrutinib.

A 43-year-old woman presented with 6 months of recurrent bilateral eye pain and redness alongside spontaneous urticaria.She ...

Significant advances in treatment for chronic spontaneous urticaria (CSU), hereditary angioedema (HAE), and anaphylaxis were presented at the American Academy of Allergy, Asthma and Immunology ...